AC Immune SA(ACIU)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 47 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ACIU Stock Analysis & AI Quality Score
AI stock analysis and institutional research for AC Immune SA (ACIU), a Healthcare sector company. ACIU is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 47 institutional filers currently hold this stock. Top institutional holders of ACIU by reported 13-F value include BVF /IL, WELLS FARGO & COMPANY/MN, MILLENNIUM MANAGEMENT, based on the most recent SEC filings. ACIU trades on the Nasdaq exchange and files with the SEC under CIK 1651625. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACIU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AC Immune SA directly from SEC EDGAR.
Get alerted when ACIU's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for AC Immune SA including:
Top Institutional Holders of ACIU
BVF INC/IL
$54.5M19,822,436 shWELLS FARGO & COMPANY/MN
$2.8M1,004,284 shMILLENNIUM MANAGEMENT LLC
$2.2M792,657 shRENAISSANCE TECHNOLOGIES LLC
$1.7M624,367 shBlackRock, Inc.
$1.4M524,278 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$1.1M405,658 shDIMENSIONAL FUND ADVISORS LP
$1.1M390,165 shPoint72 Asset Management, L.P.
$806.3K293,200 shNORTHERN TRUST CORP
$765.9K278,513 shCITADEL ADVISORS LLC
$734.9K267,233 sh
| Fund | Value | Shares |
|---|---|---|
| BVF INC/IL | $54.5M | 19,822,436 |
| WELLS FARGO & COMPANY/MN | $2.8M | 1,004,284 |
| MILLENNIUM MANAGEMENT LLC | $2.2M | 792,657 |
| RENAISSANCE TECHNOLOGIES LLC | $1.7M | 624,367 |
| BlackRock, Inc. | $1.4M | 524,278 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.1M | 405,658 |
| DIMENSIONAL FUND ADVISORS LP | $1.1M | 390,165 |
| Point72 Asset Management, L.P. | $806.3K | 293,200 |
| NORTHERN TRUST CORP | $765.9K | 278,513 |
| CITADEL ADVISORS LLC | $734.9K | 267,233 |
More Healthcare Companies
View all Healthcare →Put ACIU on your watchlist
Track score changes the day AC Immune SA files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACIU a good stock to buy?
13F Pro's AI-powered analysis of AC Immune SA (ACIU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACIU are available on the ACIU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ACIU?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACIU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AC Immune SA's investment landscape.